EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
39 hedge funds and large institutions have $68.5M invested in Eiger BioPharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
39
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.92M | |
| 2 | +$977K | |
| 3 | +$741K | |
| 4 |
Renaissance Technologies
New York
|
+$660K |
| 5 |
BlackRock
New York
|
+$513K |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$4.18M | |
| 3 | -$2.09M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.46M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$611K |